Finished
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke
NCT03592745 · Northwell Health · Updated 29 June 2021
- What is being tested
- Transcutaneous Vagus Nerve Stimulation (tVNS); Sham Transcutaneous Vagus Nerve Stimulation (tVNS)
- For
- Stroke; Cerebrovascular Accident (CVA); Hemiparesis
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 85 years. About 36 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 9 Aug 2018, ends 1 June 2021. Registered 19 July 2018.
- Results
- Posted on the registry on 29 June 2021.
In the researchers' words
The purpose of this study is to evaluate if multiple therapy sessions of Transcutaneous Vagus Nerve Stimulation (tVNS) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy in a sham stimulation condition.
Sites
- Feinstein Institute for Medical ResearchManhasset, New York, United States